Fused imidazole derivatives for the treatment of disorders mediated by aldosterone synthase and/or 11-beta-hydroxylase and/or aromatase

Details for Australian Patent Application No. 2007290695 (hide)

Owner Novartis AG

Inventors Hu, Qi-Ying; Ksander, Gary

Agent Davies Collison Cave

Pub. Number AU-A-2007290695

PCT Pub. Number WO2008/027284

Priority 60/823,562 25.08.06 US

Filing date 23 August 2007

Wipo publication date 6 March 2008

International Classifications

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61K 31/5025 (2006.01) - ortho- or peri-condensed with heterocyclic ring systems

A61K 31/5517 (2006.01)

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

Event Publications

5 March 2009 PCT application entered the National Phase

  PCT publication WO2008/027284 Priority application(s): WO2008/027284

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007290727-System for neural stimulation

2007290684-Solid citrate and tartrate salts of DPP-IV inhibitors